Estrogen priming effect on antagonist cycles in poor responded patient
Not Applicable
- Conditions
- Female infertility.Female infertility associated with anovulation
- Registration Number
- IRCT201602075942N3
- Lead Sponsor
- Vice Chancellor for Research and Technology University of medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 106
Inclusion Criteria
Women 19 to 42 years old with low ovarian reserve; Women who have not responded to treatment with short antagonist protocol and gonadotropin or the number of oocytes has been equal to or less than 3.
Exclusion criteria:
who do not respond to treatment or have a cycle of follicle has been canceled; People who have certain diseases like hypothyroidism or hyper prolactin; If patients have complications such as embolism and contraindications to estrogen
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The number of mature follicles. Timepoint: 14 day of menstrual cycle. Method of measurement: Ultrasound.;Oocytes and embryos obtained count. Timepoint: 14 day of menstrual cycle. Method of measurement: Ultrasound.
- Secondary Outcome Measures
Name Time Method Chemical and clinical pregnancy rate. Timepoint: After the delay period. Method of measurement: Tests and ultrasound.;The resulting embryo count. Timepoint: A month after a positive pregnancy test. Method of measurement: Ultrasound.